nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—head and neck cancer—salivary gland cancer	0.477	0.55	CtDrD
Docetaxel—skin cancer—salivary gland cancer	0.39	0.45	CtDrD
Docetaxel—BCL2—neck—salivary gland cancer	0.00152	0.0447	CbGeAlD
Docetaxel—MAP2—neck—salivary gland cancer	0.00132	0.0387	CbGeAlD
Docetaxel—TUBB3—connective tissue—salivary gland cancer	0.0012	0.0352	CbGeAlD
Docetaxel—MAP4—connective tissue—salivary gland cancer	0.0012	0.0352	CbGeAlD
Docetaxel—BCL2—connective tissue—salivary gland cancer	0.00109	0.032	CbGeAlD
Docetaxel—KIF11—lymph node—salivary gland cancer	0.00107	0.0315	CbGeAlD
Docetaxel—MAP2—parotid gland—salivary gland cancer	0.00107	0.0315	CbGeAlD
Docetaxel—BCL2—epithelium—salivary gland cancer	0.00104	0.0304	CbGeAlD
Docetaxel—MAP2—saliva-secreting gland—salivary gland cancer	0.00103	0.0302	CbGeAlD
Docetaxel—MAP4—lymphoid tissue—salivary gland cancer	0.000878	0.0257	CbGeAlD
Docetaxel—TUBB3—lymphoid tissue—salivary gland cancer	0.000878	0.0257	CbGeAlD
Docetaxel—TUBB2B—parotid gland—salivary gland cancer	0.000802	0.0235	CbGeAlD
Docetaxel—BCL2—lymphoid tissue—salivary gland cancer	0.000798	0.0234	CbGeAlD
Docetaxel—TUBB2B—saliva-secreting gland—salivary gland cancer	0.000768	0.0225	CbGeAlD
Docetaxel—TUBB—parotid gland—salivary gland cancer	0.000759	0.0223	CbGeAlD
Docetaxel—TUBB2A—parotid gland—salivary gland cancer	0.000755	0.0222	CbGeAlD
Docetaxel—TUBB6—parotid gland—salivary gland cancer	0.000745	0.0218	CbGeAlD
Docetaxel—TUBB4A—connective tissue—salivary gland cancer	0.000731	0.0214	CbGeAlD
Docetaxel—TUBB—saliva-secreting gland—salivary gland cancer	0.000727	0.0213	CbGeAlD
Docetaxel—TUBB2A—saliva-secreting gland—salivary gland cancer	0.000723	0.0212	CbGeAlD
Docetaxel—TUBB6—saliva-secreting gland—salivary gland cancer	0.000713	0.0209	CbGeAlD
Docetaxel—TUBB2B—connective tissue—salivary gland cancer	0.000706	0.0207	CbGeAlD
Docetaxel—TUBB2A—connective tissue—salivary gland cancer	0.000665	0.0195	CbGeAlD
Docetaxel—ABCC10—parotid gland—salivary gland cancer	0.000652	0.0191	CbGeAlD
Docetaxel—TUBB4B—parotid gland—salivary gland cancer	0.000647	0.019	CbGeAlD
Docetaxel—MAPT—lymph node—salivary gland cancer	0.00063	0.0185	CbGeAlD
Docetaxel—ABCC10—saliva-secreting gland—salivary gland cancer	0.000625	0.0183	CbGeAlD
Docetaxel—TUBB6—epithelium—salivary gland cancer	0.000622	0.0183	CbGeAlD
Docetaxel—TUBB4B—saliva-secreting gland—salivary gland cancer	0.00062	0.0182	CbGeAlD
Docetaxel—TUBB4B—connective tissue—salivary gland cancer	0.00057	0.0167	CbGeAlD
Docetaxel—TUBB4A—lymphoid tissue—salivary gland cancer	0.000534	0.0157	CbGeAlD
Docetaxel—MAP4—lymph node—salivary gland cancer	0.000495	0.0145	CbGeAlD
Docetaxel—TUBB6—lymphoid tissue—salivary gland cancer	0.000479	0.0141	CbGeAlD
Docetaxel—ABCC1—parotid gland—salivary gland cancer	0.000461	0.0135	CbGeAlD
Docetaxel—CYP1B1—connective tissue—salivary gland cancer	0.000451	0.0132	CbGeAlD
Docetaxel—BCL2—lymph node—salivary gland cancer	0.00045	0.0132	CbGeAlD
Docetaxel—EGFR—lymph node—salivary gland cancer	0.000445	0.013	CbGeAlD
Docetaxel—ABCC10—lymphoid tissue—salivary gland cancer	0.00042	0.0123	CbGeAlD
Docetaxel—TUBB4B—lymphoid tissue—salivary gland cancer	0.000417	0.0122	CbGeAlD
Docetaxel—MAP2—lymph node—salivary gland cancer	0.00039	0.0114	CbGeAlD
Docetaxel—ABCG2—parotid gland—salivary gland cancer	0.000382	0.0112	CbGeAlD
Docetaxel—ABCG2—saliva-secreting gland—salivary gland cancer	0.000366	0.0107	CbGeAlD
Docetaxel—CYP1B1—lymphoid tissue—salivary gland cancer	0.00033	0.00968	CbGeAlD
Docetaxel—TUBB4A—lymph node—salivary gland cancer	0.000301	0.00884	CbGeAlD
Docetaxel—TUBB2B—lymph node—salivary gland cancer	0.000291	0.00854	CbGeAlD
Docetaxel—TUBB—lymph node—salivary gland cancer	0.000276	0.00808	CbGeAlD
Docetaxel—TUBB2A—lymph node—salivary gland cancer	0.000274	0.00804	CbGeAlD
Docetaxel—TUBB6—lymph node—salivary gland cancer	0.00027	0.00793	CbGeAlD
Docetaxel—ABCC10—lymph node—salivary gland cancer	0.000237	0.00694	CbGeAlD
Docetaxel—TUBB4B—lymph node—salivary gland cancer	0.000235	0.00689	CbGeAlD
Docetaxel—ABCC2—lymph node—salivary gland cancer	0.00019	0.00558	CbGeAlD
Docetaxel—CYP1B1—lymph node—salivary gland cancer	0.000186	0.00546	CbGeAlD
Docetaxel—ABCC1—lymph node—salivary gland cancer	0.000167	0.00491	CbGeAlD
Docetaxel—ABCB1—epithelium—salivary gland cancer	0.000157	0.00461	CbGeAlD
Docetaxel—ABCG2—lymph node—salivary gland cancer	0.000139	0.00407	CbGeAlD
Docetaxel—ABCB1—lymphoid tissue—salivary gland cancer	0.000121	0.00355	CbGeAlD
Docetaxel—ABCB1—lymph node—salivary gland cancer	6.84e-05	0.00201	CbGeAlD
Docetaxel—TUBB—Cell Cycle—EP300—salivary gland cancer	1.73e-05	0.000176	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PHGDH—salivary gland cancer	1.73e-05	0.000176	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—CREBBP—salivary gland cancer	1.72e-05	0.000175	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—PIK3CA—salivary gland cancer	1.72e-05	0.000175	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—AQP1—salivary gland cancer	1.72e-05	0.000175	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PHGDH—salivary gland cancer	1.71e-05	0.000174	CbGpPWpGaD
Docetaxel—ABCC1—Disease—FGF16—salivary gland cancer	1.7e-05	0.000173	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—CCND1—salivary gland cancer	1.7e-05	0.000172	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—MAP2K2—salivary gland cancer	1.69e-05	0.000171	CbGpPWpGaD
Docetaxel—SLC22A7—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	1.68e-05	0.000171	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	1.68e-05	0.000171	CbGpPWpGaD
Docetaxel—EGFR—Direct p53 effectors—TP53—salivary gland cancer	1.67e-05	0.00017	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ST3GAL4—salivary gland cancer	1.67e-05	0.000169	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—AQP1—salivary gland cancer	1.66e-05	0.000169	CbGpPWpGaD
Docetaxel—EGFR—Immune System—NUP62—salivary gland cancer	1.66e-05	0.000169	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ST3GAL4—salivary gland cancer	1.65e-05	0.000168	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—PIK3CA—salivary gland cancer	1.65e-05	0.000167	CbGpPWpGaD
Docetaxel—EGFR—Regulation of Actin Cytoskeleton—PIK3CA—salivary gland cancer	1.65e-05	0.000167	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—PTEN—salivary gland cancer	1.64e-05	0.000166	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—MARCKS—salivary gland cancer	1.64e-05	0.000166	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NUP62—salivary gland cancer	1.63e-05	0.000165	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—PIK3CA—salivary gland cancer	1.62e-05	0.000165	CbGpPWpGaD
Docetaxel—ABCC1—Disease—VCAN—salivary gland cancer	1.61e-05	0.000164	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle, Mitotic—EP300—salivary gland cancer	1.6e-05	0.000163	CbGpPWpGaD
Docetaxel—EGFR—Disease—FGF16—salivary gland cancer	1.6e-05	0.000163	CbGpPWpGaD
Docetaxel—SLCO1B3—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	1.6e-05	0.000162	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle, Mitotic—CCND1—salivary gland cancer	1.59e-05	0.000162	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—HRAS—salivary gland cancer	1.59e-05	0.000162	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—TP53—salivary gland cancer	1.58e-05	0.00016	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—EP300—salivary gland cancer	1.56e-05	0.000159	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—CCND1—salivary gland cancer	1.56e-05	0.000158	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	1.56e-05	0.000158	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MC3R—salivary gland cancer	1.55e-05	0.000158	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—PIK3CA—salivary gland cancer	1.55e-05	0.000157	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—PIK3CA—salivary gland cancer	1.54e-05	0.000156	CbGpPWpGaD
Docetaxel—EGFR—Disease—NUP62—salivary gland cancer	1.53e-05	0.000156	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—PIK3CA—salivary gland cancer	1.53e-05	0.000156	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—PIK3CA—salivary gland cancer	1.52e-05	0.000155	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—HRAS—salivary gland cancer	1.52e-05	0.000155	CbGpPWpGaD
Docetaxel—EGFR—Disease—VCAN—salivary gland cancer	1.52e-05	0.000155	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PYGB—salivary gland cancer	1.52e-05	0.000155	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ISYNA1—salivary gland cancer	1.51e-05	0.000154	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—AQP1—salivary gland cancer	1.51e-05	0.000154	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—salivary gland cancer	1.5e-05	0.000153	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—AQP1—salivary gland cancer	1.5e-05	0.000152	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—HRAS—salivary gland cancer	1.5e-05	0.000152	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ST3GAL4—salivary gland cancer	1.49e-05	0.000152	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—MAP2K2—salivary gland cancer	1.49e-05	0.000151	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MAML2—salivary gland cancer	1.47e-05	0.00015	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle, Mitotic—EP300—salivary gland cancer	1.47e-05	0.000149	CbGpPWpGaD
Docetaxel—BCL2—Immune System—MAP2K2—salivary gland cancer	1.47e-05	0.000149	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—TP53—salivary gland cancer	1.45e-05	0.000147	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—PIK3CA—salivary gland cancer	1.43e-05	0.000146	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—PIK3CA—salivary gland cancer	1.43e-05	0.000146	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—PIK3CA—salivary gland cancer	1.43e-05	0.000146	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—EP300—salivary gland cancer	1.43e-05	0.000146	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—HRAS—salivary gland cancer	1.43e-05	0.000146	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—CCND1—salivary gland cancer	1.42e-05	0.000145	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—HRAS—salivary gland cancer	1.42e-05	0.000145	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—HRAS—salivary gland cancer	1.42e-05	0.000145	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—PIK3CA—salivary gland cancer	1.42e-05	0.000144	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—HRAS—salivary gland cancer	1.42e-05	0.000144	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—HRAS—salivary gland cancer	1.41e-05	0.000143	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—PIK3CA—salivary gland cancer	1.41e-05	0.000143	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—PIK3CA—salivary gland cancer	1.4e-05	0.000143	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—salivary gland cancer	1.39e-05	0.000141	CbGpPWpGaD
Docetaxel—EGFR—Disease—MAML2—salivary gland cancer	1.39e-05	0.000141	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—PTEN—salivary gland cancer	1.38e-05	0.000141	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	1.38e-05	0.000141	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—NOTCH1—salivary gland cancer	1.38e-05	0.00014	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—NUP62—salivary gland cancer	1.36e-05	0.000139	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—PIK3CA—salivary gland cancer	1.35e-05	0.000138	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—DTX4—salivary gland cancer	1.35e-05	0.000138	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—VCAN—salivary gland cancer	1.35e-05	0.000137	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	1.35e-05	0.000137	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	1.35e-05	0.000137	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—PTEN—salivary gland cancer	1.34e-05	0.000136	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—PIK3CA—salivary gland cancer	1.33e-05	0.000135	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—HRAS—salivary gland cancer	1.33e-05	0.000135	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—HRAS—salivary gland cancer	1.33e-05	0.000135	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—HRAS—salivary gland cancer	1.33e-05	0.000135	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—NUP62—salivary gland cancer	1.32e-05	0.000134	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—HRAS—salivary gland cancer	1.31e-05	0.000134	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—EP300—salivary gland cancer	1.31e-05	0.000133	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—VCAN—salivary gland cancer	1.31e-05	0.000133	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	1.31e-05	0.000133	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—HRAS—salivary gland cancer	1.3e-05	0.000132	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—HRAS—salivary gland cancer	1.3e-05	0.000132	CbGpPWpGaD
Docetaxel—EGFR—Immune System—FGFR4—salivary gland cancer	1.28e-05	0.00013	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—EP300—salivary gland cancer	1.27e-05	0.00013	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—PIK3CA—salivary gland cancer	1.27e-05	0.000129	CbGpPWpGaD
Docetaxel—EGFR—Immune System—FBXW7—salivary gland cancer	1.26e-05	0.000128	CbGpPWpGaD
Docetaxel—ABCC1—Disease—JAG1—salivary gland cancer	1.26e-05	0.000128	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—HRAS—salivary gland cancer	1.25e-05	0.000127	CbGpPWpGaD
Docetaxel—ABCC1—Disease—FGFR4—salivary gland cancer	1.25e-05	0.000127	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—CREBBP—salivary gland cancer	1.25e-05	0.000127	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PHGDH—salivary gland cancer	1.24e-05	0.000126	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—TP53—salivary gland cancer	1.24e-05	0.000126	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—MARCKS—salivary gland cancer	1.23e-05	0.000125	CbGpPWpGaD
Docetaxel—ABCC1—Disease—FBXW7—salivary gland cancer	1.23e-05	0.000125	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—HRAS—salivary gland cancer	1.23e-05	0.000125	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—salivary gland cancer	1.23e-05	0.000125	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—NUP62—salivary gland cancer	1.2e-05	0.000122	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	1.2e-05	0.000122	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ST3GAL4—salivary gland cancer	1.19e-05	0.000121	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—VCAN—salivary gland cancer	1.19e-05	0.000121	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—NUP62—salivary gland cancer	1.19e-05	0.000121	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	1.19e-05	0.000121	CbGpPWpGaD
Docetaxel—EGFR—Disease—JAG1—salivary gland cancer	1.19e-05	0.000121	CbGpPWpGaD
Docetaxel—EGFR—Disease—FGFR4—salivary gland cancer	1.18e-05	0.00012	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—VCAN—salivary gland cancer	1.18e-05	0.00012	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—HRAS—salivary gland cancer	1.18e-05	0.000119	CbGpPWpGaD
Docetaxel—EGFR—Disease—FBXW7—salivary gland cancer	1.16e-05	0.000118	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—PIK3CA—salivary gland cancer	1.16e-05	0.000117	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	1.15e-05	0.000117	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PYGB—salivary gland cancer	1.15e-05	0.000117	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	1.14e-05	0.000116	CbGpPWpGaD
Docetaxel—ABCC2—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	1.14e-05	0.000116	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—salivary gland cancer	1.14e-05	0.000115	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	1.13e-05	0.000115	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FGF16—salivary gland cancer	1.12e-05	0.000114	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TP53—salivary gland cancer	1.12e-05	0.000114	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CREBBP—salivary gland cancer	1.11e-05	0.000112	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CREBBP—salivary gland cancer	1.09e-05	0.000111	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—AQP1—salivary gland cancer	1.08e-05	0.00011	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CDH1—salivary gland cancer	1.08e-05	0.00011	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—HRAS—salivary gland cancer	1.07e-05	0.000109	CbGpPWpGaD
Docetaxel—EGFR—Immune System—FOXO3—salivary gland cancer	1.06e-05	0.000108	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CDH1—salivary gland cancer	1.05e-05	0.000107	CbGpPWpGaD
Docetaxel—ABCC1—Disease—FOXO3—salivary gland cancer	1.04e-05	0.000106	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—TP53—salivary gland cancer	1.03e-05	0.000104	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	1e-05	0.000102	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	9.93e-06	0.000101	CbGpPWpGaD
Docetaxel—EGFR—Disease—FOXO3—salivary gland cancer	9.8e-06	9.97e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—PIK3CA—salivary gland cancer	9.77e-06	9.93e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MAML2—salivary gland cancer	9.73e-06	9.89e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	9.65e-06	9.81e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—MAP2K2—salivary gland cancer	9.49e-06	9.65e-05	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—PIK3CA—salivary gland cancer	9.42e-06	9.58e-05	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—TP53—salivary gland cancer	9.38e-06	9.54e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PHGDH—salivary gland cancer	9.35e-06	9.51e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ISYNA1—salivary gland cancer	9.33e-06	9.48e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	9.21e-06	9.36e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—HRAS—salivary gland cancer	9.04e-06	9.19e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ST3GAL4—salivary gland cancer	9e-06	9.15e-05	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—HRAS—salivary gland cancer	8.72e-06	8.86e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MAP2K2—salivary gland cancer	8.67e-06	8.82e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—NUP62—salivary gland cancer	8.59e-06	8.73e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—EP300—salivary gland cancer	8.53e-06	8.67e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—VCAN—salivary gland cancer	8.52e-06	8.67e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MAP2K2—salivary gland cancer	8.49e-06	8.64e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	8.47e-06	8.61e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	8.46e-06	8.6e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—JAG1—salivary gland cancer	8.31e-06	8.45e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FGFR4—salivary gland cancer	8.27e-06	8.41e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	8.2e-06	8.33e-05	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—HRAS—salivary gland cancer	8.18e-06	8.32e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AQP1—salivary gland cancer	8.18e-06	8.31e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FBXW7—salivary gland cancer	8.14e-06	8.28e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	8.08e-06	8.22e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MAP2K2—salivary gland cancer	8.01e-06	8.14e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—PTEN—salivary gland cancer	7.9e-06	8.03e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	7.82e-06	7.95e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—PTEN—salivary gland cancer	7.78e-06	7.91e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—MARCKS—salivary gland cancer	7.6e-06	7.73e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—PTEN—salivary gland cancer	7.58e-06	7.71e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—EP300—salivary gland cancer	7.53e-06	7.66e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—CREBBP—salivary gland cancer	7.47e-06	7.6e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—EP300—salivary gland cancer	7.42e-06	7.54e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PYGB—salivary gland cancer	7.07e-06	7.19e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NOTCH1—salivary gland cancer	6.96e-06	7.08e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FOXO3—salivary gland cancer	6.87e-06	6.98e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	6.81e-06	6.92e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	6.59e-06	6.7e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—NOTCH1—salivary gland cancer	6.56e-06	6.67e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—NUP62—salivary gland cancer	6.48e-06	6.59e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CREBBP—salivary gland cancer	6.44e-06	6.55e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—VCAN—salivary gland cancer	6.43e-06	6.54e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CDH1—salivary gland cancer	6.39e-06	6.5e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CREBBP—salivary gland cancer	6.31e-06	6.41e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	5.98e-06	6.08e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CREBBP—salivary gland cancer	5.95e-06	6.05e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—HRAS—salivary gland cancer	5.84e-06	5.93e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	5.78e-06	5.88e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PHGDH—salivary gland cancer	5.76e-06	5.86e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MAP2K2—salivary gland cancer	5.61e-06	5.7e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—PIK3CA—salivary gland cancer	5.57e-06	5.66e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	5.55e-06	5.64e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—PIK3CA—salivary gland cancer	5.49e-06	5.58e-05	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	5.37e-06	5.46e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—PIK3CA—salivary gland cancer	5.35e-06	5.44e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PTEN—salivary gland cancer	5.34e-06	5.43e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CREBBP—salivary gland cancer	5.28e-06	5.37e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—HRAS—salivary gland cancer	5.15e-06	5.24e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CREBBP—salivary gland cancer	5.11e-06	5.2e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—EP300—salivary gland cancer	5.09e-06	5.18e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HRAS—salivary gland cancer	5.08e-06	5.16e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AQP1—salivary gland cancer	5.04e-06	5.12e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HRAS—salivary gland cancer	4.95e-06	5.03e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CREBBP—salivary gland cancer	4.65e-06	4.73e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CREBBP—salivary gland cancer	4.61e-06	4.69e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PTEN—salivary gland cancer	4.6e-06	4.68e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NOTCH1—salivary gland cancer	4.59e-06	4.67e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTEN—salivary gland cancer	4.51e-06	4.58e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—EP300—salivary gland cancer	4.39e-06	4.46e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—EP300—salivary gland cancer	4.3e-06	4.37e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTEN—salivary gland cancer	4.25e-06	4.32e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CREBBP—salivary gland cancer	4.16e-06	4.23e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—EP300—salivary gland cancer	4.05e-06	4.12e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NUP62—salivary gland cancer	3.99e-06	4.06e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—VCAN—salivary gland cancer	3.96e-06	4.03e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PTEN—salivary gland cancer	3.77e-06	3.84e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PIK3CA—salivary gland cancer	3.77e-06	3.83e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PTEN—salivary gland cancer	3.65e-06	3.71e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—EP300—salivary gland cancer	3.6e-06	3.66e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PIK3CA—salivary gland cancer	3.55e-06	3.61e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—EP300—salivary gland cancer	3.48e-06	3.54e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CREBBP—salivary gland cancer	3.33e-06	3.39e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PTEN—salivary gland cancer	3.32e-06	3.38e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PTEN—salivary gland cancer	3.29e-06	3.35e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—HRAS—salivary gland cancer	3.29e-06	3.34e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PIK3CA—salivary gland cancer	3.25e-06	3.3e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PIK3CA—salivary gland cancer	3.18e-06	3.23e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—EP300—salivary gland cancer	3.17e-06	3.22e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—EP300—salivary gland cancer	3.14e-06	3.19e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCND1—salivary gland cancer	3.08e-06	3.13e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HRAS—salivary gland cancer	3e-06	3.05e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PIK3CA—salivary gland cancer	3e-06	3.05e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PTEN—salivary gland cancer	2.97e-06	3.02e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HRAS—salivary gland cancer	2.94e-06	2.99e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—EP300—salivary gland cancer	2.84e-06	2.88e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—HRAS—salivary gland cancer	2.77e-06	2.82e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CA—salivary gland cancer	2.66e-06	2.71e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CA—salivary gland cancer	2.57e-06	2.62e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CREBBP—salivary gland cancer	2.51e-06	2.56e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTEN—salivary gland cancer	2.38e-06	2.42e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CA—salivary gland cancer	2.34e-06	2.38e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CA—salivary gland cancer	2.32e-06	2.36e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—EP300—salivary gland cancer	2.27e-06	2.31e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CA—salivary gland cancer	2.1e-06	2.13e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TP53—salivary gland cancer	2.03e-06	2.06e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HRAS—salivary gland cancer	1.94e-06	1.97e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTEN—salivary gland cancer	1.8e-06	1.83e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—EP300—salivary gland cancer	1.71e-06	1.74e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CA—salivary gland cancer	1.68e-06	1.71e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CREBBP—salivary gland cancer	1.55e-06	1.57e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CA—salivary gland cancer	1.27e-06	1.29e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTEN—salivary gland cancer	1.11e-06	1.12e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—EP300—salivary gland cancer	1.05e-06	1.07e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	7.8e-07	7.93e-06	CbGpPWpGaD
